Grown Rogue International (GRUSF) Current Deferred Revenue (2014 - 2023)
Grown Rogue International (GRUSF) recorded quarterly Current Deferred Revenue of -$20667.5 in Q4 2023, down 148.73% quarter-over-quarter from $42415.6 in Q3 2023, and up 71.22% on a YoY basis from -$12070.6 in Q4 2022.
Grown Rogue International (GRUSF) Current Deferred Revenue (2014 - 2023) Analysis & Trends
Grown Rogue International's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at -$20667.5 for Q4 2023.
- In Q4 2023, Current Deferred Revenue rose 71.22% year-over-year to -$20667.5; the TTM figure through Oct 2023 stood at -$20667.5 (up 71.22% YoY), while the FY2023 annual figure was -$20667.5, down 173.75% from the prior year.
- Current Deferred Revenue was -$20667.5 for Q4 2023 at Grown Rogue International, down from $42415.6 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $84600.0 in Q1 2021 to a low of -$71817.9 in Q4 2022.
- Historically, Current Deferred Revenue has averaged $15856.0 across 5 years, with a median of $37500.0 in 2019.
- The sharpest annual moves came in 2020 and 2023: Current Deferred Revenue sank 200.0% in 2020, then jumped 71.22% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $35000.0 in 2019, then tumbled by 200.0% to -$35000.0 in 2020, then jumped by 214.29% to $40000.0 in 2021, then tumbled by 279.54% to -$71817.9 in 2022, then jumped by 71.22% to -$20667.5 in 2023.
- The last three Current Deferred Revenue figures came in at -$20667.5 (Q4 2023), $42415.6 (Q3 2023), and $52318.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -20,667.53 |
| Jul 31, 2023 | 42,415.60 |
| Jan 31, 2023 | 52,318.00 |
| Oct 31, 2022 | -71,817.94 |
| Apr 30, 2021 | 40,000.00 |
| Jan 31, 2021 | 84,600.00 |
| Oct 31, 2020 | -35,000.00 |
| Oct 31, 2019 | 35,000.00 |
| Feb 28, 2015 | -193,440.49 |
| Nov 30, 2014 | -147,690.01 |
| Aug 31, 2014 | 164,270.89 |